Relay Therapeutics Earnings Preview

Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2026-02-26. Here's what investors need to know before the announcement.

Analysts estimate that Relay Therapeutics will report an earnings per share (EPS) of $-0.39.

Anticipation surrounds Relay Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Performance in Previous Earnings

During the last quarter, the company reported an EPS missed by $0.02, leading to a 7.35% drop in the share price on the subsequent day.

Here's a look at Relay Therapeutics's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.41	-0.48	-0.51	-0.55
EPS Actual	-0.43	-0.41	-0.46	-0.45
Price Change %	-7.35	-7.74	-5.12	-13.33

Stock Performance

Shares of Relay Therapeutics were trading at $9.18 as of February 24. Over the last 52-week period, shares are up 182.15%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Relay Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.